Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
21.14 USD | +19.00% | +41.63% | +345.83% |
02:47pm | COVID shots for JN.1 variant neutralize newer strains, vaccine makers say | RE |
Jun. 03 | COVID shots should target JN.1, KP.2 subvariants in 2024-25 campaign, US FDA staff says | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+345.83% | 2.49B | |
+52.14% | 55.7B | |
+41.08% | 39.91B | |
-6.08% | 39.57B | |
-5.56% | 28.16B | |
+15.38% | 26.3B | |
-19.66% | 18.94B | |
+30.89% | 12.17B | |
+26.61% | 12.12B | |
+1.31% | 12.12B |
- Stock Market
- Equities
- NVAX Stock
- News Novavax, Inc.
- Novavax Unveils COVID-19 Vaccine Licensing Deal With Sanofi; Shares Soar